Table 3.
Author/s | Population | Intervention | Outcomes | Effects | ||
---|---|---|---|---|---|---|
CrM+HMB Vs CON/PLG | CrM+HMB Vs CrM | CrM+HMB Vs HMBG | ||||
Crowe et al., (2003) [38] | 28 male elite rugby players (24.9 ± 0.7 years) |
Controlled CrM: 3 g/day HMB: 3 g/day Duration: 6 weeks |
|
|
|
|
Faramarzi et al., (2009) [35] | 24 soccer players (21.6 ± 0.1 years) |
Randomized, placebo- controlled CrM: 3 g/day HMB: 3 g/day Duration: 6 days |
|
|
|
|
Jówko et al., (2001) [36] | 40 healthy males (21.0 ± 2.1 years) |
Randomized, double-blind, placebo-controlled CrM: 20 g/day (first 1 week) + 10 g/day (2 weeks) HMB: 3 g/day Duration: 3 weeks |
|
|
|
|
O’Connor & Crowe (2003) [39] | 27 male elite rugby players (18–32 years) |
Controlled CrM: 3 g/day HMB: 3 g/day Duration: 6 weeks |
|
|
|
|
Zajac et al., (2003) [37] | 52 well trained basketball players (25.6 ± 5.6 years) |
Randomized, placebo- controlled CrM: 15 g/day (first 5 days) + 5 g/day (rest of the days) HMB: 3 g/day Duration: 30 days |
|
|
|
|
CrM: Creatine monohydrate supplementation, HMB: HMB supplementation, CON/PLG: placebo or control group, HMBG: HMB supplementation group, CrMG: Creatine monohydrate supplementation group, CK: creatine kinase, LA: blood lactate, LDH: Lactate dehydrogenase; ↑: Increase, ↓: Decrease, : No effect.